Capricorn Fund Managers’s Takeda Pharmaceutical TAK Stock Holding History

Capricorn Fund Managers’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-204,892	Closed	-$3.17M	–	85
2023 Q3	$3.17M	Sell	204,892 -663,525	-76%	-$10.3M	1.1%	24
2023 Q2	$13.6M	Buy	+868,417	New	+$14.2M	4.9%	6
2022 Q4	–	Sell	-277,783	Closed	-$3.6M	–	103
2022 Q3	$3.6M	Buy	+277,783	New	+$3.86M	1.13%	23
2022 Q1	–	Sell	-1,568,306	Closed	-$21.4M	–	115
2021 Q4	$21.4M	Buy	+1,568,306	New	+$22M	6.01%	4

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Capricorn Fund Managers's TAK Position: Q4 2023 in Review

Capricorn Fund Managers sold out of Takeda Pharmaceutical (TAK) in Q4 2023, closing a stake of 204,892 shares — an estimated $3.17M sold.

Capricorn Fund Managers first reported a position in TAK in Q4 2021 and held it in 4 quarters. The position peaked at $21.4M in Q4 2021. 307 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

Capricorn Fund Managers reported no remaining Takeda Pharmaceutical position as of Q4 2023 after selling out during the quarter.
Capricorn Fund Managers sold 204,892 Takeda Pharmaceutical shares in Q4 2023, an estimated $3.17M.
Capricorn Fund Managers first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 4 quarters.
Capricorn Fund Managers's Takeda Pharmaceutical position peaked at $21.4M in Q4 2021.
307 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on Capricorn Fund Managers's 13F filing for Q4 2023, filed 10 Jan 2024.